Tool Create startup animated videos in minutes, not in hours! 

 175 days ago
 Source: finsmes.com

Pinpoint Therapeutics Raises $1M in Seed Funding

Quick Summary

Pinpoint Therapeutics, Inc., a Philadelphia, PA-based biopharmaceutical company focused on the development of novel autophagy inhibitors to treat cancer, raised $1 million in debt financing. The company’s novel compounds target a recently discovered enzyme in the autophagy pathway called PPT1, which is highly expressed across most cancers. These inhibitors could be applied to a broad range of cancers alone or in combination with other treatments to overcome therapy resistance. Pinpoint will develop first-in-class autophagy inhibitors into clinical drugs for testing in a range of treatment-refractory cancers. Pinpoint was launched in 2018 through PCI Ventures, a division of the Penn Center for Innovation (PCI) at the University of Pennsylvania.

Disclaimer: This story is auto-aggregated & summarized by a computer program and has not been created by StartupAround.

Read Original Article

Popular Topics

Get the best stories from Startup Around on Telegram